SPIRE HEALTHCARE GROUP PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.84 EUR | 0.00% |
|
+0.71% | +7.58% |
| 05-09 | Spire Healthcare touts strong trading, backs outlook | AN |
| 05-09 | Spire Healthcare Reiterates FY24 Guidance | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company has a low valuation given the cash flows generated by its activity.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company does not generate enough profits, which is an alarming weak point.
- One of the major weak points of the company is its financial situation.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +7.58% | 1.22B | - | ||
| -32.87% | 13.6B | B+ | ||
| +4.15% | 11.78B | B+ | ||
| -3.60% | 11.49B | B | ||
| +10.37% | 10.78B | B+ | ||
| +27.20% | 8.59B | B | ||
| -9.39% | 7.29B | A- | ||
| +7.99% | 6.85B | B- | ||
| +9.12% | 6.41B | D | ||
| +15.67% | 4.39B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SPI Stock
- S00 Stock
- Ratings Spire Healthcare Group plc
